Dr. Jean-François Boileau, co-lead of the RCN's Breast Disease Site Group discusses the impact of systematic pre-screening on clinical trial accrual.
Dr. Johnathan Spicer (left) and Dr. Jason Agulnik, co-leads of the RCN Lung Disease Site Group, take questions after their presentation on a major initiative to improve the trajectory of care of lung cancer patients.
The RCN was honoured to have the CEOs of its three partner hospitals (from left to right: Dr. Lawrence Rosenberg (CIUSSS Centre-Ouest-de-l'Île-de Montréal), Dr. PIerre Gfeller (McGill University Health Centre) and Ms. Lynne McVey (CIUSSS Ouest-de-l'Île-de Montréal) on hand to speak about the importance of collaborating to improve trajectories of care.
The RCN Clinical Lead, Dr. Wilson Miller opens the Retreat with a review of the past year's initiatives.
Keynote speaker Dr. Monika Krzyzanowska of Princess Margaret Cancer Centre provided input on patient-centered models to manage symptoms during cancer treatment.
The RCN's International Advisory Board member, Dr Joe Jacobson of Dana-Farber Cancer Centre, provides feedback about trajectories of care.
Moderator Dr. Adrian Langleben looks on during a discussion between Dr. Reza Forghani, Dr. Nicole Ezer and Dr. Alan Spatz on the challenges of streamlining the diagnostic process.
Dr. Tarek Hijal discusses the challenges and opportunities in delivering radiation therapy.
Erin Cook, Clinical Administrative Coordinator Oncology at the Jewish General Hospital, presents issues in delivering systemic therapy during the morning breakout.
Greg David (centre), Vice Chair of the Rossy Family Foundation, discusses the major RCN initiative on improving trajectories of care with RCN Lung Disease Site co-lead Dr Jason Agulnik (right).
RCN partners Bram Freedman of the JGH Foundation; Ariel Dayan-Medalsy of the Cedars Cancer Foundation; Alan Maislan of the board for the CIUSSS West-Central Montreal; and Jeff Shamie of the Cedars Cancer Foundation discussed the morning session during the break.
CQI Research Grant recipient Dr. Reza Forghani (right) discusses his findings on AI-guided radiomics for detection of cervical nodal metastases.
Close to 210 health care professionals, researchers and patients turned out to discuss ways to improve quality and harmonize care across the RCN partner hospitals.
Carmen Loiselle, Director of the McGill Cancer Nursing Program, presented her research on the impact of nurse navigators on the patient experience.
Patient advocate Ekaterina Tsimberis highlights the importance of using patient-reported outcomes to guide patient care.
Lucie Tardif, nursing director for the MUHC Cancer Care Mission discusses the challenges of integrating trajectories of care for lung cancer patients.
Dr Ari Meguerditchian, lead of the RCN's Cancer Quality & Innovation Program, discusses upcoming funding opportunities and how to maximize your chances of having your project make the cut.
Maya Jeanty, clinical unit director for oncology at St. Mary`s Hospital Center discussed the impact that RCN bursaries for certification and specialized training have had on nursing staff.
Dr. Armen Aprikian (left) moderates a discussion around upcoming initiatives based on National Surgical Quality Improvement Program (NSQIP) data.
Dr Wilson Miller, clinical lead of the Rossy Cancer Network, opens the discussion on optimizing access for clinical trials during a breakout session.
Representatives of the institutional boards and partner foundations of the RCN meet with the institutional CEOs and members of the RCN Executive Committee before the Retreat.